Tag - pharmaceuticals

 
Menu
Search
 
April 10, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
WORLD / Science & Health / FOCUS
Oct 7, 2021
A Chilean tree holds hope for new vaccines — if supplies last
Quillay trees, technically known as Quillaja saponaria, are rare evergreens native to Chile that have long been used by the indigenous Mapuche people to make soap and medicine.
Japan Times
WORLD
Sep 20, 2021
Pfizer COVID-19 shot safely bolsters antibodies in younger kids
In a trial, two shots of a 10 microgram dose — one-third of the adult shot — produced antibody levels comparable to those seen in a trial of 16- to 25-year-olds who got the adult dose.
Japan Times
JAPAN
Sep 1, 2021
Japan finds another Moderna vial suspected to contain foreign substance
Kanagawa Prefecture said it had put the suspected lot of the firm's COVID-19 vaccine on hold after about 3,790 people had already received shots from the same lot.
Japan Times
JAPAN / Explainer
Aug 30, 2021
Foreign substances in Japan's Moderna shots: Here's what you need to know
Other possibly contaminated batches have been reported in recent days, but experts say health risks are low.
JAPAN / FOCUS
Aug 24, 2021
Japan turns to antibody cocktails as 'new weapon' in fight against pandemic
The government has widened the use of the drug Ronapreve, but some doctors say it needs to go further and make it available to patients isolating at home too.
Japan Times
COMMENTARY / World
Aug 12, 2021
Can Moderna buy its way into the $200 billion club?
Moderna's COVID-19 windfall sees its market valuation surged by more than $100 billion since May.
JAPAN
Aug 11, 2021
Japan backs 'revolutionary' COVID-19 drug Ronapreve to help tame crisis
The antibody cocktail, intended for mildly and moderately ill patients, could in the near future be used to treat those quarantining at home, helping to ease the strain on hospitals.
Japan Times
BUSINESS / Companies
Aug 4, 2021
SoftBank built a $5 billion stake in pharma giant Roche
Roche's diagnostics unit reacted swiftly to the pandemic, and now sales are boosted by its COVID-19 testing business.
Japan Times
COMMENTARY / World
Jul 30, 2021
Legitimate pain research is more crucial than ever
Researchers today say opioids are not only dangerous; they are not a good long-term solution for chronic pain sufferers. The relief tends to wane with time.
JAPAN
Jul 29, 2021
Even with delta surging, experts say two vaccine doses is enough for now
U.S. firm Pfizer Inc. has called for an additional third shot of its COVID-19 vaccine, citing new data showing its efficacy tails off after six months.
Japan Times
WORLD / Science & Health / FOCUS
Jul 21, 2021
Global quest underway to speed up COVID-19 vaccine trials
Researchers are trying to determine just what level of antibodies a vaccine must produce to provide protection against the illness.
Japan Times
WORLD / FOCUS
Jul 16, 2021
World carved up into haves and have-nots by mRNA vaccine access
The cutting-edge technology, which made its debut during the pandemic, has proven more effective than any other in staving off infections and serious illness from the coronavirus.
Japan Times
WORLD
Jul 9, 2021
Pfizer outlines booster plans while regulators signal caution
Pfizer Inc. plans to request U.S. emergency authorization in August for a third booster dose of its COVID-19 vaccine.
Japan Times
WORLD
Jul 9, 2021
Countries using Chinese-made vaccines and AstraZeneca increasingly eye boosters
Officials are being motivated by concerns that delta and other variants appear to be breaking down defenses of vaccines not made from the supereffective messenger RNA technology.
Japan Times
BUSINESS / Companies
Jul 9, 2021
Fujifilm says pivot to health care and chips paid off in pandemic
Over the past decade, Fujifilm parlayed its expertise in film and chemicals to move into medical diagnostics, pharmaceutical manufacturing and supplying materials to chipmakers.
Japan Times
WORLD / Science & Health
Jul 7, 2021
Studies show vaccines are effective against delta variant
Jerusalem, however, announced that the effectiveness of the Pfizer-BioNTech vaccine was seen to be 64% against all COVID-19 infections — down from about 95% in May.
Japan Times
WORLD
Jun 20, 2021
Many Brazilians insist on Pfizer even as nation passes 500,000 COVID-19 deaths
In Sao Paulo, people demand the U.S. company's shots at public clinics and often walk out if none are available.
Japan Times
WORLD / Science & Health
Jun 20, 2021
Don’t count on needing a COVID-19 booster shot, top WHO scientist says
As some governments prepare for COVID-19 booster shots targeting more infectious virus variants, health authorities say it's too early to tell if they will be required.
Wall Street will regret helping the world burn
Wall Street banks, under political pressure and tempted by short-term gains, are abandoning climate commitments and pouring billions into fossil fuels, risking both environmental catastrophe and massive future economic losses.
Trump's tariff gambit leaves Asia stunned and scrambling
U.S. President Donald Trump speaks as he attends the National Republican Congressional Committee dinner in Washington on Tuesday. Trump allowed new tariffs — including a 24% levy on Japan — to go into effect as scheduled on Wednesday.
Japan and U.S. appoint tariff negotiators after Ishiba-Trump phone call
Economic revitalization minister Ryosei Akazawa enters the Prime Minister's Office in Tokyo on Tuesday.
Japanese makers rush to mitigate possible Nankai Trough earthquake damage
Toyota is considering transferring some production in the key Tokai region, which is expected to be hit hard in a Nankai Trough earthquake, to the Tohoku and Kyushu regions.
Why Japan is running out of rice — and farmers to grow it
An ongoing shortage of rice has resulted in rising prices for Japan's main food staple.
After a tumultuous buildup, a first look at the Osaka Expo
A large statue of Osaka Expo mascot Myaku Myaku sits near the east entrance of the event's venue in Yumeshima island, Osaka, on Wednesday.
Japan gets a new U.S. ambassador — and he has his work cut out for him
George Glass, U.S. President Donald Trump's pick to be ambassador to Japan, attends a Senate Foreign Relations Committee confirmation hearing in Washington on March 13.
Online art scene eager to go offline, at least for the moment
Digital artist Polygon1993 revels in the physicality of nostalgic technology, making art out of materials such as miniature CDs, holographic prints layered with plexiglass shards and a giant custom-made floppy disk.
Tottori takes a bold leap forward in the arts
The city of Kurayoshi in Tottori Prefecture celebrated the opening of its public art museum with festivities such as a parade that drew 1,000 revelers.
Haruki Murakami TV adaptation revisits 30 years of watershed moments
Though Haruki Murakami's trademark whiff of offbeat existentialism is threaded throughout NHK's "After the Quake," the final episode — conceived as a sequel to the story "Super-Frog Saves Tokyo" — is the most stylized, featuring an anthropomorphic talking frog (voiced by Non) and his erstwhile associate Katagiri (Koichi Sato).

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

An ongoing shortage of rice has resulted in rising prices for Japan's main food staple.
Why Japan is running out of rice — and farmers to grow it
By Alex K.T. Martin

SUSTAINABLE JAPAN

BOARDING & INTERNATIONAL SCHOOL DAY 2025 (Sunday, April 20)
BOARDING & INTERNATIONAL SCHOOL DAY 2025 (Sunday, April 20)

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER